LogicBio Therapeutics, Inc. — Form D
LogicBio Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-01-21. The offering totals $5.4M, of which $4.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2016-01-21
- Form: D
- Accession: 0001664106-16-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.4M
- Amount sold: $4.0M
- Remaining: $1.4M
- Minimum investment: $1
- Investors: 1
- Date of first sale: 2016-01-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-255626
Issuer
- Name: LogicBio Therapeutics, Inc.
- CIK: 0001664106
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 700 MAIN STREET, CAMBRIDGE, MA, 02139
- Phone: 61(0)428-338-594
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Adi Barzel | Director | Foster City, CA |
| Leszek Lisowski | Director | Foster City, CA |
| Adi Barzel | Executive Officer | Foster City, CA |
| Leszek Lisowski | Executive Officer | Foster City, CA |
| Leon A Chen | Director | Cambridge, MA |
| MARC A RUBENSTEIN | Executive Officer | CAMBRIDGE, MA |
| TOMER A KARIV | Director | CAMBRIDGE, MA |
| EREZ A CHIMOVITS | Director | CAMBRIDGE, MA |
| SOFIA A IOANNIDOU | Director | CAMBRIDGE, MA |
| DANIEL A O'CONNELL | Director | CAMBRIDGE, MA |
| FREDERIC A CHEREAU | Director | CAMBRIDGE, MA |
| FREDERIC A CHEREAU | Executive Officer | CAMBRIDGE, MA |
| Mark A Kay | Director | Camillus, NY |
Other filings by this issuer (1)
More